18624911000001102: Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Trade family\Casodex\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Apr 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

63882501000001113 Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

78313601000001116 Casodex 150mg tablets (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Is a	Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has active ingredient	Bicalutamide	false	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has specific active ingredient	Bicalutamide	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Is a	Casodex	true	Inferred relationship	Existential restriction modifier
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd) 28 tablet	Has AMP	True	Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
63882501000001113	Casodex 150mg tablets (Doncaster Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
78313601000001116	Casodex 150mg tablets (DE Pharmaceuticals)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module